3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Lymphoid
1
Head & Neck
1
Classical hematology
1
Conditions
Trismus
1
Radiation Injuries
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Lymphedema
1
Fibrosis
1
Interventions
Cisplatin
315
Radiotherapy
139
Cetuximab
133
pembrolizumab
131
Docetaxel
122
Carboplatin
119
Radiotherapy, Intensity-Modulated
97
Fluorouracil
94
Paclitaxel
92
Nivolumab
64
Gemcitabine
50
toripalimab
46
Radiation
44
Drug Therapy
39
Capecitabine
39
Magnetic Resonance Spectroscopy
38
Surgical Procedures, Operative
33
camrelizumab
31
130-nm albumin-bound paclitaxel
29
apatinib
27
tislelizumab
26
Chemoradiotherapy
26
Specimen Handling
25
Bevacizumab
24
durvalumab
23
Albumin-Bound Paclitaxel
23
nimotuzumab
22
lenvatinib
21
Sorafenib
21
Platinum
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Physical Therapy Modalities
×
Head & Neck
×
Clear all
NCT00780312
2013-07-02
HOHF
Rigshospitalet, Denmark
Phase 2
Completed
97 enrolled